Scilex Holding (SCLXW) Other Operating Expenses (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Other Operating Expenses of -$18.1 million in Q1 2026, down 7.0% quarter-over-quarter from -$16.9 million in Q4 2025.

Scilex Holding (SCLXW) Other Operating Expenses (2020 - 2026) Analysis & Trends

Scilex Holding's Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$18.1 million for Q1 2026.

  • In Q1 2026, Other Operating Expenses changed N/A year-over-year to -$18.1 million; the TTM figure through Mar 2026 stood at -$25.9 million (down 579.86% YoY), while the FY2025 annual figure was -$12.2 million, changed N/A from the prior year.
  • Other Operating Expenses was -$18.1 million for Q1 2026 at Scilex Holding, down from -$16.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.5 million in Q4 2023 to a low of -$18.1 million in Q1 2026.
  • Historically, Other Operating Expenses has averaged $418558.1 across 5 years, with a median of $4.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Other Operating Expenses jumped 4961.73% in 2022, then tumbled 143.83% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $5.5 million in 2022, then grew by 0.14% to $5.5 million in 2023, then retreated by 2.81% to $5.4 million in 2024, then slumped by 413.15% to -$16.9 million in 2025, then slipped by 7.0% to -$18.1 million in 2026.
  • The last three Other Operating Expenses figures came in at -$18.1 million (Q1 2026), -$16.9 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.06 Mn
Dec 31, 2025 -16.88 Mn
Sep 30, 2025 4.70 Mn
Jun 30, 2025 4.38 Mn
Jun 30, 2024 5.39 Mn
Mar 31, 2024 -2.02 Mn
Dec 31, 2023 5.55 Mn
Sep 30, 2023 4.42 Mn
Jun 30, 2023 5.20 Mn
Mar 31, 2023 4.62 Mn
Dec 31, 2022 5.54 Mn
Sep 30, 2022 526,359.00
Jun 30, 2022 3.00 Mn
Mar 31, 2022 -485,807.00
Dec 31, 2021 1.52 Mn
Sep 30, 2021 -1.16 Mn
Jun 30, 2021 -61,609.00
Mar 31, 2021 1.49 Mn
Dec 31, 2020 6,276.00
Sep 30, 2020 856.00